Recent News

• 03.31.2025 - Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
• 03.31.2025 - Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
• 03.24.2025 - Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
• 03.24.2025 - Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases

Recent Filings

• 03.31.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.31.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.28.2025 - 8-K Current report
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 3 Initial statement of beneficial ownership of securities